IHAM
ALNY icon

Integral Health Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Integral Health Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,000
Closed -$23.9M – 92
2025
Q4 		$23.9M Hold
60,000
– – 1.18% 27
2025
Q3 		$27.4M Buy
60,000
+5,000
+9% +$2.04M 1.85% 13
2025
Q2 		$17.9M Buy
55,000
+5,000
+10% +$1.38M 1.64% 19
2025
Q1 		$13.5M Buy
50,000
+5,000
+11% +$1.28M 1.44% 19
2024
Q4 		$10.6M Buy
45,000
+20,000
+80% +$5.26M 0.9% 42
2024
Q3 		$6.88M Buy
+25,000
New +$6.51M 0.77% 36
2024
Q2 		– Sell
-50,000
Closed -$7.47M – 77
2024
Q1 		$7.47M Buy
50,000
+5,000
+11% +$834K 0.69% 54
2023
Q4 		$8.61M Buy
+45,000
New +$7.67M 1.17% 38
2023
Q3 		– Sell
-52,000
Closed -$9.88M – 68
2023
Q2 		$9.88M Buy
52,000
+32,000
+160% +$6.34M 1.22% 34
2023
Q1 		$4.01M Sell
20,000
-15,000
-43% -$3.15M 0.81% 49
2022
Q4 		$8.32M Sell
35,000
-35,000
-50% -$7.47M 1.75% 24
2022
Q3 		$14M Buy
70,000
+23,034
+49% +$4.39M 2.72% 10
2022
Q2 		$6.85M Buy
+46,966
New +$6.66M 1.41% 25
2022
Q1 		– Sell
-20,000
Closed -$3.39M – 74
2021
Q4 		$3.39M Sell
20,000
-5,000
-20% -$929K 0.94% 34
2021
Q3 		$4.72M Hold
25,000
– – 1.36% 27
2021
Q2 		$4.24M Sell
25,000
-15,000
-38% -$2.2M 1.17% 35
2021
Q1 		$5.65M Buy
40,000
+25,000
+167% +$3.76M 1.61% 22
2020
Q4 		$1.95M Sell
15,000
-10,000
-40% -$1.34M 0.58% 46
2020
Q3 		$3.64M Buy
+25,000
New +$3.55M 1.11% 32

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Integral Health Asset Management's ALNY Position: Q1 2026 in Review

Integral Health Asset Management sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 60,000 shares — an estimated $23.9M sold.

Integral Health Asset Management first reported a position in ALNY in Q3 2020 and held it in 19 quarters. The position peaked at $27.4M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Integral Health Asset Management reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 60,000 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
  • Integral Health Asset Management first reported a position in Alnylam Pharmaceuticals in Q3 2020 and held it in 19 quarters.
  • Integral Health Asset Management's Alnylam Pharmaceuticals position peaked at $27.4M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.